ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Milestone Pharmaceuticals Announces First Patient Randomized in NODE-301 Trial
August 10, 2018Milestone Pharmaceuticals announced that the first patient has been randomized in its Phase 3 clinical study of etripamil. Etripamil is a new investigational, rapid-onset, short-acting calcium channel blocker administered intranasally by the patient desig
Pharma Sources Insight January 2025
